Sürdürülebilir Kalkınma Amaçları
Bu dergideki yayınlar
1 →- MakaleYalnız künye2023Predicting hospitalization by TAPSE/SPAP and the role of spironolactone in asymptomatic heart failure patients
Aydinyilmaz, Faruk; Guliyev, Ilkin; Özbeyaz, Nail B.; Algül, Engin; Aker, Mert; Sahan, Haluk F.; Erzurum, Muhammed; Felekoglu, Mehmet A.; Kalkan, Kamuran
Aim: To appraise the prediction of tricuspid annular plane systolic excursion (TAPSE)/systolic pulmonary artery pressure (SPAP) with regard to hospitalization and the effect of spironolactone use. Materials & methods: A total of 245 patients were evaluated for the study. Patients were followed for 1 year and cardiovascular outcomes were determined. Results: It was determined that TAPSE/SPAP was an independent predictor of hospitalization. A 0.1-mmHg decrease in TAPSE/SPAP was associated with a 9% increase in relative risk. No event was observed above the 0.47 level. Negative correlation with TAPSE (uncoupling) began in the spironolactone group when SPAP was >= 43 and in nonusers when SPAP was 38 (Pearson's correlation coefficient: -,731 vs -,383; p < 0.001 vs p = 0.037). Conclusion: TAPSE/SPAP measurement may be useful in predicting 1-year hospitalization in asymptomatic heart failure patients. This ratio was also found to be higher in patients who used spironolactone.
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| creativeworkseries.issn | 1752-0363 | |
| creativeworkseries.issn | 1752-0371 | |
| dc.date.accessioned | 2026-10-22T10:29:21.807877136Z | |
| dc.date.available | 2026-10-22T10:29:21.807877136Z | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/16445 | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | BIOMARKERS IN MEDICINE | |
| dspace.entity.type | Journal |

